ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982

Program Announcement: Breast Cancer Research

May 28, 1993

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005